NEW YORK--(BUSINESS WIRE)--$OSH--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on behalf of those who acquired Oak Street Health, Inc. (“Oak Street” or the “Company”) (NYSE: OSH) securities from August 6, 2020 through November 8, […]
NEW YORK--(BUSINESS WIRE)--#Class--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against eHealth, Inc. (“eHealth” or the “Company”) (NASDAQ: EHTH) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or […]
NEW YORK--(BUSINESS WIRE)--#Class--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against NRx Pharmaceuticals, Inc. (“NRx” or the “Company”) (NASDAQ: NRXP, NRXPW) in the United States District Court for the District of Delaware on behalf of all persons and entities who purchased […]
SAN DIEGO--(BUSINESS WIRE)--#NRXPWstock--Robbins Geller Rudman & Dowd LLP announces that purchasers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP; NRXPW) securities between June 1, 2021 and November 4, 2021, inclusive (the “Class Period”) have until March 21, 2022 to seek appointment as lead plaintiff in Dal Bosco v. NRx Pharmaceuticals, Inc., No. 22-cv-00066 (D. Del.). Commenced on […]
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Talis common stock pursuant and/or traceable to the registration statement and prospectus (collectively, […]
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) and certain of its officers, on behalf of shareholders who: (1) purchased or otherwise acquired Owlet between March 31, 2021, and October 4, 2021, inclusive (the “Class Period”); […]
NEW YORK--(BUSINESS WIRE)--#Class--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Lightspeed Commerce Inc. (“Lightspeed” or the “Company”) (NYSE: LSPD) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who […]
NEW YORK--(BUSINESS WIRE)--$NTRA #NTRA--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Natera, Inc. (NASDAQ: NTRA) resulting from allegations that Natera may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Natera securities you may be […]
NEW YORK--(BUSINESS WIRE)--#EHTH--WHY: Rosen Law Firm, a global investor rights law firm, informs purchasers of the securities of eHealth, Inc. (NASDAQ: EHTH) between April 26, 2018 and July 23, 2020, both dates inclusive (the “Class Period”), of the updated March 18, 2022 lead plaintiff deadline in the action In re eHealth Inc. Securities Litigation, No. […]
RADNOR, Pa.--(BUSINESS WIRE)--$TLIS--The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Talis Biomedical Corporation (“Talis”) (NASDAQ: TLIS). The action charges Talis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects. As […]
Lawyer Monthly is a news website and monthly legal publication with content that is entirely defined by the significant legal news from around the world.
We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you consent to the use of cookies. Privacy PolicyOkI do not consent
